Cargando…
Mechanisms of Lysophosphatidic Acid-Mediated Lymphangiogenesis in Prostate Cancer
Prostate cancer (PCa) is the most common noncutaneous cancer in men worldwide. One of its major treatments is androgen deprivation therapy, but PCa frequently relapses as aggressive castration resistant local tumors and distal metastases. Hence, the development of novel agents or treatment modalitie...
Autores principales: | Wu, Pei-Yi, Lin, Yueh-Chien, Huang, Yuan-Li, Chen, Wei-Min, Chen, Chien-Chin, Lee, Hsinyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6266502/ https://www.ncbi.nlm.nih.gov/pubmed/30384405 http://dx.doi.org/10.3390/cancers10110413 |
Ejemplares similares
-
Interleukin-1β Expression Is Required for Lysophosphatidic Acid-Induced Lymphangiogenesis in Human Umbilical Vein Endothelial Cells
por: Lin, Chih-Hsin, et al.
Publicado: (2010) -
Lysophosphatidic acid receptor LPA(3) prevents oxidative stress and cellular senescence in Hutchinson–Gilford progeria syndrome
por: Chen, Wei‐Min, et al.
Publicado: (2019) -
Lysophosphatidic Acid Enhances Vascular Endothelial Growth Factor-C Expression in Human Prostate Cancer PC-3 Cells
por: Lin, Chuan-En, et al.
Publicado: (2012) -
Lysophosphatidic Acid Receptor Antagonists and Cancer: The Current Trends, Clinical Implications, and Trials
por: Lin, Yu-Hsuan, et al.
Publicado: (2021) -
Arf6 in lymphatic endothelial cells regulates lymphangiogenesis by controlling directional cell migration
por: Lin, Yueh-Chien, et al.
Publicado: (2017)